SCHEMBL2065764

SCHEMBL2065764

CN(CCOc1ccc(Br)cc1C=C1SC(=S)NC1=O)C(=O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTP4A3 O75365 10/20 0.64
PTPN1 P18031 2/20 0.51
GSK3B P49841 2/20 0.49
NAT1 P18440 1/20 0.45
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MGAM O43451 1/20 0.44
GAA P10253 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
ADAMTS5 Q9UNA0 1/20 0.44
CISD1 Q9NZ45 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10090321 1.00 PTP4A3 (0.64) PTP4A3PTPN1GSK3BNAT1MEN1
SCHEMBL14464062 0.90 PTP4A3 (0.64) PTP4A3PTPN1GSK3BMEN1POLB
SCHEMBL10090319 0.88 PTP4A3 (0.61) PTP4A3PTPN1GSK3BCISD1
SCHEMBL2065355 0.88 PTP4A3 (0.61) PTP4A3PTPN1GSK3BCISD1
SCHEMBL14464067 0.87 PTP4A3 (0.60) PTP4A3PTPN1GSK3BCISD1
SCHEMBL2067673 0.87 PTP4A3 (0.61) PTP4A3PTPN1GSK3BNAT1MEN1
SCHEMBL10090316 0.87 PTP4A3 (0.61) PTP4A3PTPN1GSK3BNAT1MEN1
SCHEMBL10090186 0.84 PTP4A3 (0.57) PTP4A3PTPN1GSK3BMEN1MAPT
SCHEMBL2065103 0.84 PTP4A3 (0.57) PTP4A3PTPN1GSK3BMEN1MAPT
SCHEMBL2066518 0.84 PTP4A3 (0.57) PTP4A3PTPN1GSK3BCISD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148541-B2 Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2012-04-03 US claimed
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-02-12 US claimed
US-8148541-B2 Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2012-04-03 US disclosed
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same PTPRR, PTPRG, PTPRS PTP4A3 28/4885PTPN1 26/4885GSK3B 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.